HIV cure: what lies beneath? | Dr Virginie Gautier | TEDxUCD
Jan12

HIV cure: what lies beneath? | Dr Virginie Gautier | TEDxUCD

Published on 11 Dec 2015 HIV infects T-cells, ‘high-jacking’ their cellular machinery and turning them into virus-producing ‘factories’. A small proportion of these cells can create a persisting pool of latently infected cells, which constitute the HIV latent reservoir. There, the virus remains dormant, silent and hidden from patients’ immune defences and from otherwise effective anti-retroviral treatments. In her TEDxUCD 2015 talk...

Read More
“I’m Undetectable. Do I Have to Disclose to a Hook-Up?”
Aug20

“I’m Undetectable. Do I Have to Disclose to a Hook-Up?”

Check out #AskTyler‘s take on this perennial topic over on hivplusmag.com.  ...

Read More
GenerationsHIV.org – the new Digital Quilt
Jun05

GenerationsHIV.org – the new Digital Quilt

GenerationsHIV.org, a new website for films about HIV & AIDS, was launched today.  The founders, Marc Smolowitz and Jörg Fockele, hope that it will become become the most comprehensive video platform on the internet about HIV and AIDS. 5th June every year marks the anniversary of the first time the Centers for Disease Control and Prevention publicly acknowledged the virus in 1981, admitting that a handful of gay men in Los Angeles...

Read More
An Aggressive Antiretroviral Treatment
Jun05

An Aggressive Antiretroviral Treatment

A second baby born with HIV now has no evidence of the virus in her system following an aggressive antiretroviral treatment regimen given shortly after birth. The New York Times, Read the full article in The New York Times from 5 March 2014   The “Mississippi Baby” — now a toddler — still has undetectable HIV viral load more than 40 months after interrupting the antiretroviral therapy started within hours...

Read More
Anti-retroviral Therapy: Why and how it works even against HIV cell-to-cell transmission.
Jun05

Anti-retroviral Therapy: Why and how it works even against HIV cell-to-cell transmission.

A new study has tested a panel of anti-HIV drugs for their ability to suppress cell-to-cell transmission of the virus.  The results reveal differences between different drugs, with implications for the prevention of drug resistance and for the development of new effective anti-HIV drugs. Read the full article in Medical News Today, 3 March...

Read More